McKesson Appoints Brian Tyler as President and Chief Operating Officer
July 31 2018 - 9:00AM
Business Wire
McKesson Corporation (NYSE:MCK) today announced that Brian S.
Tyler, Ph.D., has been appointed president and chief operating
officer, McKesson Corporation, effective August 2, 2018. Tyler will
report to John Hammergren, chairman and chief executive officer,
and will become a member of the executive committee.
“Brian is ideally suited to lead McKesson’s global operations
based on his deep industry knowledge, outstanding track record as a
business leader, and his commitment to operational excellence and
customer success,” said Hammergren. “His broad experience as the
president of multiple McKesson businesses provides him with the
ideal background and perspective to help lead McKesson’s strategic
initiative and drive long-term growth.”
Previously Chairman of the Management Board, McKesson Europe,
Tyler has also served as president of McKesson North American
Pharmaceutical Distribution and Services, McKesson U.S.
Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty
Health, as well as executive vice president of corporate strategy
and business development. His direct reports will include:
- President, McKesson U.S. Pharmaceutical
and Specialty Health
- President, McKesson
Medical-Surgical
- CEO, McKesson Canada
- President, McKesson Prescription
Technology Solutions (MRxTS)
- President, Transformation
Initiatives
- Chairman, Management Board, McKesson
Europe
“McKesson has outstanding products, services and solutions, and
world class talent,” said Tyler. “With these assets, the company is
uniquely positioned to drive innovation across the healthcare
supply chain that will improve value for our business partners and
enable better, more cost-effective patient care. I look forward to
working with our customers, manufacturing partners and McKesson’s
more than 78,000 associates to deliver on that potential and
accelerate McKesson’s growth.”
Tyler earned his Ph.D. and M.A. from the University of Chicago,
Department of Economics in 1994, where he studied under a grant
from the National Science Foundation, and earned his B.A. in
economics with high honors from University of California Santa Cruz
in 1989.
McKesson also announced today that Nick Loporcaro, president of
McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has
decided to leave McKesson to pursue other opportunities. Upon
Loporcaro’s departure on August 10, Tyler will lead this segment
directly until Loporcaro’s replacement has been named.
“Nick is a talented executive and we know he will accomplish
great things in his next chapter,” said Hammergren. “He has led
McKesson Canada, McKesson Specialty Health and most recently, the
combined U.S. Pharmaceutical and Specialty Health business. We
thank him for his many contributions to McKesson and wish him the
greatest success.”
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE 500,
is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and
healthcare information technology. McKesson partners with
pharmaceutical manufacturers, providers, pharmacies, governments
and other organizations in healthcare to help provide the right
medicines, medical products and healthcare services to the right
patients at the right time, safely and cost-effectively. United by
our ICARE shared principles, our employees work every day to
innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named the “Most Admired Company” in the
healthcare wholesaler category by FORTUNE, a “Best Place to Work”
by the Human Rights Campaign Foundation, and a
top military-friendly company by Military Friendly. For
more information, visit www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180731005536/en/
McKesson CorporationCraig Mercer, 415-983-8391 (Investors and
Financial Media)Craig.Mercer@McKesson.comorApril Marks,
415-732-1384 (General and Business
Media)April.Marks@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Jun 2024 to Jul 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Jul 2023 to Jul 2024